3-(3-Chloro-quinoxalin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H22ClN3O3, MW: 363.84
![]() |
- $429 - $499.61
- Product name: 3-(3-Chloro-quinoxalin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H22ClN3O3, MW: 363.84
- CAS: 939986-62-6
- MF: C18H22ClN3O3
- MW: 363.84
- EINECS:
- MDL Number:MFCD09607625
- Synonyms:3-(3-Chloro-quinoxalin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H22ClN3O3, MW: 363.84;3-[(3-Chloro-2-quinoxalinyl)oxy]-1-piperidinecarboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 3-[(3-chloro-2-quinoxalinyl)oxy]-, 1,1-dimethylethyl ester
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0295642
- Product descriptionTERT-BUTYL-3-((3-CHLOROQUINOXALIN-2-YL)OXY)PIPERIDINE-1-CARBOXYLATE 95.00%
- Packaging5MG
- Price$499.61
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM142052
- Product descriptiontert-butyl3-((3-chloroquinoxalin-2-yl)oxy)piperidine-1-carboxylate 95%
- Packaging1g
- Price$429
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11008256
- Product descriptiontert-Butyl3-((3-chloroquinoxalin-2-yl)oxy)piperidine-1-carboxylate 95+%
- Packaging1g
- Price$455
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0295642 | TERT-BUTYL-3-((3-CHLOROQUINOXALIN-2-YL)OXY)PIPERIDINE-1-CARBOXYLATE 95.00% | 5MG | $499.61 | 2021-12-16 | Buy |
Chemenu | CM142052 | tert-butyl3-((3-chloroquinoxalin-2-yl)oxy)piperidine-1-carboxylate 95% | 1g | $429 | 2021-12-16 | Buy |
Crysdot | CD11008256 | tert-Butyl3-((3-chloroquinoxalin-2-yl)oxy)piperidine-1-carboxylate 95+% | 1g | $455 | 2021-12-16 | Buy |
Properties
Density :1.269
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|